Study of TP-3654 in Patients With Advanced Solid Tumors
Clinical trial NCT03715504 · COMPLETED
Trial details
- NCT number
- NCT03715504
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2021-03-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.